Literature DB >> 27644162

Effects of continuous positive airway pressure and isocapnic-hypoxia on cerebral autoregulation in patients with obstructive sleep apnoea.

Xavier Waltz1,2, Andrew E Beaudin1, Patrick J Hanly2,3,4, Georgios D Mitsis5, Marc J Poulin1,2,6,7,8.   

Abstract

KEY POINTS: Altered cerebral autoregulation (CA) in obstructive sleep apnoea (OSA) patients may contribute to increased stroke risk in this population; the gold standard treatment for OSA is continuous positive airway pressure, which improves cerebrovascular regulation and may decrease the risk of stroke. Isocapnic-hypoxia impairs CA in healthy subjects, but it remains unknown in OSA whether impaired CA is further exacerbated by isocapnic-hypoxia and whether it is improved by treatment with continuous positive airway pressure. During normoxia, CA was altered in the more severe but not in the less severe OSA patients, while, in contrast, during isocapnic-hypoxia, CA was similar between groups and tended to improve in patients with more severe OSA compared to normoxia. From a clinical perspective, one month of continuous positive airway pressure treatment does not improve CA. From a physiological perspective, this study suggests that sympathetic overactivity may be responsible for altered CA in the more severe OSA patients. ABSTRACT: Cerebral autoregulation (CA) impairment may contribute to the increased risk of stroke associated with obstructive sleep apnoea (OSA). It is unknown if impaired CA is further exacerbated by isocapnic-hypoxia and whether it is improved by treatment of OSA with continuous positive airway pressure (CPAP). CA was assessed during wakefulness in 53 OSA patients (50.3 ± 9.3 years) and 21 controls (49.8 ± 8.6 years) at baseline and following a minimum of 1 month of effective CPAP therapy (OSA patients, n = 40). Control participants (n = 21) performed a follow-up visit to control for time effects within OSA patients between baseline and the post-CPAP visit. Beat-by-beat middle cerebral artery blood flow velocity and mean arterial blood pressure (MBP), and breath-by-breath end-tidal partial pressure of CO2 (P ET ,CO2) were monitored. CA was determined during normoxia and isocapnic-hypoxia using transfer function (phase and gain) and coherence analysis (including multiple and partial coherence (using MBP and P ET ,CO2 as inputs)) in the very low frequency range (0.03-0.07 Hz). OSA patients were divided into two subgroups (less severe and more severe) based upon the median respiratory disturbance index (RDI). During normoxia, the more severe OSA patients (RDI 45.9 ± 10.3) exhibited altered CA compared to controls and the less severe OSA patients (RDI 24.5 ± 5.9). In contrast, during isocapnic-hypoxia, CA was similar between groups. CPAP had no effect on CA. In conclusion, CA is altered in the more severe OSA patients during normoxia but not during isocapnic-hypoxia and CPAP treatment does not impact CA.
© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society.

Entities:  

Mesh:

Year:  2016        PMID: 27644162      PMCID: PMC5134415          DOI: 10.1113/JP272967

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  51 in total

1.  Autonomic neural control of dynamic cerebral autoregulation in humans.

Authors:  Rong Zhang; Julie H Zuckerman; Kenichi Iwasaki; Thad E Wilson; Craig G Crandall; Benjamin D Levine
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

2.  Association of sleep-disordered breathing and the occurrence of stroke.

Authors:  Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; T Douglas Bradley
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

3.  Dynamics of the cerebral blood flow response to step changes in end-tidal PCO2 and PO2 in humans.

Authors:  M J Poulin; P J Liang; P A Robbins
Journal:  J Appl Physiol (1985)       Date:  1996-09

Review 4.  Cerebral autoregulation.

Authors:  O B Paulson; S Strandgaard; L Edvinsson
Journal:  Cerebrovasc Brain Metab Rev       Date:  1990

5.  Obstructive sleep apnoea: longer respiratory event lengths in patients with heart failure.

Authors:  Christina Efken; Thomas Bitter; Natalie Prib; Dieter Horstkotte; Olaf Oldenburg
Journal:  Eur Respir J       Date:  2012-09-27       Impact factor: 16.671

Review 6.  Obstructive sleep apnea, stroke, and cardiovascular diseases.

Authors:  Kanika Bagai
Journal:  Neurologist       Date:  2010-11       Impact factor: 1.398

7.  Cerebral autoregulation in patients with obstructive sleep apnea syndrome during wakefulness.

Authors:  N Nasr; A Pavy-Le Traon; M Czosnyka; M Tiberge; E Schmidt; V Larrue
Journal:  Eur J Neurol       Date:  2009-03       Impact factor: 6.089

8.  Digital monitoring of sleep-disordered breathing using snoring sound and arterial oxygen saturation.

Authors:  F G Issa; D Morrison; E Hadjuk; A Iyer; T Feroah; J E Remmers
Journal:  Am Rev Respir Dis       Date:  1993-10

Review 9.  Obstructive sleep apnoea and stroke.

Authors:  Henry Yaggi; Vahid Mohsenin
Journal:  Lancet Neurol       Date:  2004-06       Impact factor: 44.182

10.  Arterial stiffness in obstructive sleep apnoea: Is there a difference between daytime and night-time?

Authors:  Sevinc Sarinc Ulasli; Muzaffer Sariaydin; Gulay Ozkececi; Ersin Gunay; Bilal Halici; Mehmet Unlu
Journal:  Respirology       Date:  2016-07-05       Impact factor: 6.424

View more
  3 in total

1.  Continuous positive airway pressure might not solve your cerebral autoregulation problem if you have obstructive sleep apnoea.

Authors:  Stephen Payne
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

2.  Sleep and Stroke: New Updates on Epidemiology, Pathophysiology, Assessment, and Treatment.

Authors:  H Lee Lau; Tanja Rundek; Alberto R Ramos
Journal:  Curr Sleep Med Rep       Date:  2019-05-02

3.  Impact of mandibular advancement device therapy on cerebrovascular reactivity in patients with carotid atherosclerosis combined with OSAHS.

Authors:  Lu Qin; Na Li; Junyao Tong; Zeliang Hao; Lili Wang; Ying Zhao
Journal:  Sleep Breath       Date:  2021-01-07       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.